Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PegIntron Injection Surveillance Plan.

Trial Profile

PegIntron Injection Surveillance Plan.

Phase of Trial: Phase IV

Latest Information Update: 30 Apr 2015

At a glance

  • Drugs Peginterferon alfa-2b (Primary)
  • Indications Hepatitis C
  • Focus Adverse reactions
  • Sponsors Merck & Co
  • Most Recent Events

    • 10 Dec 2010 Actual initiation date changed from Aug 2006 to Jun 2006 as reported by ClinicalTrials.gov.
    • 25 Dec 2009 Actual end date (Nov 2009) added as reported by ClinicalTrials.gov.
    • 25 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top